|Anatomy of the Prostate|
|Copyright © Nucleus Medical Media, Inc.|
Reasons for Test
- Monitor treatment effectiveness for prostate cancer
- Help determine if cancer has returned in men who have already been treated for prostate cancer
- Test for other conditions, like prostatitis , or benign prostatic hyperplasia
What to Expect
Prior to Test
- Ejaculation can cause PSA levels to rise. Avoid sexual activity for 24 hours before testing.
- Some procedures can elevate PSA levels. Schedule your PSA test several weeks after any of these:
- Wait several weeks after successful treatment of prostate infections.
Some medicines can lower PSA levels. Tell your doctor if you are taking:
Description of Test
How Long Will It Take?
Will It Hurt?
Call Your Doctor
- Bleeding from the puncture site
- Red, swollen, or painful puncture site
- If you have not heard from your doctor in 1-2 weeks
American Cancer Society http://www.cancer.org
Urology Care Foundation http://www.urologyhealth.org
Canadian Cancer Society http://www.cancer.ca
Prostate Cancer Canada http://www.prostatecancer.ca
Fang J, Metter EJ, et al. PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/mL. Urology . 2002;59:889-893.
How did the USPSTF arrive at this recommendation? US Preventative Services Task Force website. Available at: http://www.uspreventiveservicestaskforce.org/prostatecancerscreening/prostatecancerfaq.htm . Published May 2012. Accessed September 12, 2012.
Members of the Prostate-Specific Antigen Best Practice Statement Panel (2009). Prostate-Specific Antigen Best Practice Statement: 2009 Update. Available at: http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/psa09.pdf . Accessed April 17, 2013.
Prostate cancer screening. EBSCO DynaMed website. http://www.ebscohost.com/dynamed/what.php . Updated March 15, 2013. Accessed April 17, 2013.
Prostate-Specific Antigen (PSA) Test. National Cancer Institute website. Available at: http://www.cancer.gov/cancertopics/factsheet/Detection/PSA . Updated July 24, 2012. Accessed April 17, 2013.
Screening for prostate cancer: current recommendation. US Preventative Services Task Force website. Available at: http://www.uspreventiveservicestaskforce.org/prostatecancerscreening.htm . Published May 2012. Accessed April 17, 2013.
Stephan C, Stroebel G, et al. The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL. Cancer . 2005;104:993-1003.
5/6/2009 DynaMed's Systematic Literature Surveillance https://dynamed.ebscohost.com/about/about-us : Schröder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med . 2009;360:1320-1328.
- Reviewer: Adrienne Carmack, MD
- Review Date: 06/2013 -
- Update Date: 06/24/2013 -